OVATF (Ovation Science) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 02, 2026)


What is Ovation Science 5-Year Yield-on-Cost %?

Ovation Science OVATF 5-Year Yield-on-Cost % is 0.00 as of Jul. 02, 2026. The stock has 4 warning signs investors should review. Among 516 Drug Manufacturers companies, Ovation Science ranks worse than 193798.26% on this metric.

Ovation Science's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Ovation Science's 5-Year Yield-on-Cost % or its related term are showing as below:



OVATF's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.345
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Ovation Science  (OTCPK:OVATF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Ovation Science 5-Year Yield-on-Cost % Related Terms

OVATF vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovation Science 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Ovation Science's 5-Year Yield-on-Cost % falls into.


Ovation Science 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Ovation Science is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Ovation Science (OVATF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ovation Science and its competitors. According to the industry distribution chart, Ovation Science ranks #999999 out of 516 companies in the Drug Manufacturers industry.
Is Ovation Science's 5-Year Yield-on-Cost % too high?
Ovation Science's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Ovation Science ranks #999999 out of 516 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Ovation Science's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ovation Science ranks #999999 out of 516 companies for 5-Year Yield-on-Cost %. This places Ovation Science in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.35, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Ovation Science and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ovation Science's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ovation Science stock overvalued right now?
Ovation Science (OVATF) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 30% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Ovation Science (OVATF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ovation Science Business Description

Other Exchanges OVAT:Canada
Address 1166 Alberni Street, Suite 1003, Vancouver, BC, CAN, V6E 3Z3
Ovation Science Inc. is a Canada-based company mainly engaged in the business of providing topical and transdermal cannabis products under the Ovation brand label, utilizing patented Invisicare delivery technology. The Company operates in one reportable operating segment, the sub-licensing and sales of cannabis products that utilize Invisicare, a patented polymer-based technology for topical and transdermal skin care products.